https://www.statnews.com/2020/05/21/kadmon-to-seek-fda-approval-of-drug-targeting-graft-versus-host-disease-following-positive-study-outcome/?utm_source=STAT+Newsletters&utm_campaign=be6ea652b2-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-be6ea652b2-149692869

STAT Plus: Kadmon to seek FDA approval of drug targeting graft-versus-host disease following positive study outcome

By ADAM FEUERSTEIN

HYACINTH EMPINADO/STAT

The New York-based biotech said it intends to submit to the Food and Drug Administration in October, taking advantage of an agency pilot program.

READ MORE